Fisher Funds Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.81M Sell
324,451
-18,796
-5% -$492K 0.22% 99
2026
Q1
$9.64M Sell
343,247
-57,887
-14% -$1.54M 0.28% 83
2025
Q4
$10M Hold
401,134
0.26% 85
2025
Q3
$10.2M Hold
401,134
0.27% 81
2025
Q2
$9.72M Sell
401,134
-44,570
-10% -$1.04M 0.23% 80
2025
Q1
$11.3M Hold
445,704
0.27% 75
2024
Q4
$11.8M Buy
+445,704
New +$12.1M 0.28% 70

Other funds holding PFE

Fisher Funds Management's PFE Position: Q2 2026 in Review

Fisher Funds Management reduced its Pfizer (PFE) stake by 5.5% in Q2 2026, selling an estimated $492K and leaving 324,451 shares worth $7.81M. The position accounts for 0.22% of the portfolio, ranked #99.

Fisher Funds Management first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $11.8M in Q4 2024. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Fisher Funds Management held 324,451 shares of Pfizer worth $7.81M as of Q2 2026.
  • Fisher Funds Management sold 18,796 Pfizer shares in Q2 2026, an estimated $492K.
  • Pfizer made up 0.22% of Fisher Funds Management's portfolio in Q2 2026, its #99 holding.
  • Fisher Funds Management first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • Fisher Funds Management's Pfizer position peaked at $11.8M in Q4 2024.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Fisher Funds Management's 13F filing for Q2 2026, filed 14 Jul 2026.